ImmunoDeficiency and ECMO for Acute respiratory failure
This study will provide, for the first time, detailed descriptive data on the characteristics, the complication and the outcome of adult’s immunocompromised patients receiving ECMO for ARDS.
ANCHOR is a multicenter, randomized, controlled trial. It’s primary objective is to determine if early VA-ECMO in conjunction with optimal medical treatment would improve clinical outcomes 30 days following randomization as compared with optimal medical treatment alone in patients with acute myocardial infarction complicated by cardiogenic shock.
The XXL Study
Gas eXchange eXtracorporeaL techniques: How many candidates in the ICU?
Prospective, observational study screening patients that meet criteria for ECLS to evaluate the incidence of patients who may be candidates for the different forms of extracorporeal support in ICU.